What is Acadia Pharmaceuticals's revenue?

Acadia Pharmaceuticals (ACAD) generated $1.1B in revenue over the trailing twelve months, up 9.9% year over year.

Is Acadia Pharmaceuticals profitable?

Acadia Pharmaceuticals reported $375.7M in net income over the trailing twelve months, a 34.3% net margin.

What are Acadia Pharmaceuticals's profit margins?

Gross margin is 91.5% and operating margin is 7.4%, with a 34.3% net margin.

What is Acadia Pharmaceuticals's earnings per share?

Acadia Pharmaceuticals's diluted EPS over the trailing twelve months is $2.21.

Where does Acadia Pharmaceuticals's income statement data come from?

Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Acadia Pharmaceuticals ACAD Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Total revenue	$1.1B+9.9%	$1.07B+11.9%	$1.05B+12.7%	$1.02B+14.4%	$996.28M+22.4%
Total cost of revenue	$93.4M+17.8%	$89M+8.7%	$84.58M+8.5%	$81.79M+11.0%	$79.28M+26.0%
Gross profit	$1B+9.3%	$982.51M+12.2%	$962.54M+13.1%	$937.1M+14.7%	$917M+22.1%
Gross margin	91.5%-0.6pp	91.7%+0.2pp	91.9%+0.3pp	92%+0.2pp	92%-0.2pp
Research and development	$327.41M+1.7%	$328.8M+8.4%	$344.78M+28.0%	$323.55M-10.0%	$321.84M-5.9%
Selling, general and administrative	$593.54M+17.1%	$548.89M+12.4%	$523.36M+11.4%	$523.25M+20.5%	$506.81M+22.6%
Total costs & expenses	$1.01B+33.2%	$966.69M+33.0%	$806.2M-1.3%	$782.08M-9.9%	$761.41M-7.0%
Operating income	$80.91M-65.6%	$104.81M-54.6%	$240.92M—	$236.81M—	$234.87M—
Operating margin	7.4%-16.2pp	9.8%-14.3pp	23%—	23.2%—	23.6%—
Interest expense	$31.88M+14.4%	$31.72M+24.6%	$30.4M+31.0%	$28.74M+38.5%	$27.85M+47.1%
Other income (expense), net	$2.33M+9.4%	$2.37M+30.1%	$2.35M+88.3%	$2.33M+7.0%	$2.13M+286%
Income before income taxes	$115.11M-56.5%	$138.9M-46.2%	$273.67M—	$267.88M—	$264.85M—
Income tax expense	-$260.54M-824%	-$252.1M-897%	$12.5M—	$45.72M—	$35.97M—
Net income	$375.65M+64.1%	$391M+72.7%	$261.17M+103%	$222.16M+627%	$228.88M+13,485%
Net margin	34.3%+11.3pp	36.5%+12.8pp	24.9%+11.1pp	21.8%+18.4pp	23%+23.2pp
Diluted earnings per share	$2.21+61.3%	$2.30+69.1%	$1.55+98.7%	$1.33+639%	$1.37+13,800%
EBITDA	$92.71M-62.6%	$116.57M-52.7%	$254.97M—	$250.48M—	$248.18M—
EBITDA margin	8.5%-16.4pp	10.9%-14.9pp	24.3%—	24.6%—	24.9%—
EBIT	$80.91M-65.6%	$104.81M-54.6%	$240.92M—	$236.81M—	$234.87M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Acadia Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Acadia Pharmaceuticals's revenue?: Acadia Pharmaceuticals (ACAD) generated $1.1B in revenue over the trailing twelve months, up 9.9% year over year.
Is Acadia Pharmaceuticals profitable?: Acadia Pharmaceuticals reported $375.7M in net income over the trailing twelve months, a 34.3% net margin.
What are Acadia Pharmaceuticals's profit margins?: Gross margin is 91.5% and operating margin is 7.4%, with a 34.3% net margin.
What is Acadia Pharmaceuticals's earnings per share?: Acadia Pharmaceuticals's diluted EPS over the trailing twelve months is $2.21.
Where does Acadia Pharmaceuticals's income statement data come from?: Every line is extracted from Acadia Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.